Social media

The therapeutic landscape for obesity is changing rapidly. Endpoints focused only on weight loss are no longer enough, and regulators expect measures that capture the entire patient experience. Watch our recent webinar t...

The therapeutic landscape for obesity is changing rapidly. Endpoints focused only on weight loss are no longer enough, and regulators expect measures that capture the entire patient experience. Watch our recent webinar t...

We are proud to share that ICON has been recognised among the Forbes World’s Top Companies for Women 2025. This recognition reflects our continued commitment to creating an inclusive workplace where women can thrive, lea...

We are proud to share that ICON has been recognised among the Forbes World’s Top Companies for Women 2025. This recognition reflects our continued commitment to creating an inclusive workplace where women can thrive, lea...

Are you navigating complex IRT challenges or planning your next clinical trial? ICON’s experts will be onsite and ready to meet with pharma and biotech leaders looking to optimise their IRT strategy. Whether you're explo...

USP compounding may be fast — but is it costing you quality, compliance, and insight? Join our webinar to learn why GMP is the smarter choice for early phase trials. During this session we will discuss: • The differences...

USP compounding may be fast — but is it costing you quality, compliance, and insight? Join our webinar to learn why GMP is the smarter choice for early phase trials. During this session we will discuss: • The differences...

We’re looking forward to joining the conversation at #OCTNewEngland. On October 15 at 11:30 AM, our General Partner and VP of Operations, Stacey Flattery, will speak on: “Maneuvering with agility in a challenging landsc...

We’re looking forward to joining the conversation at #OCTNewEngland. On October 15 at 11:30 AM, our General Partner and VP of Operations, Stacey Flattery, will speak on: “Maneuvering with agility in a challenging landsc...

From molecule to market - see how ICON supports oncology sponsors with tailored strategies, from logistics to regulatory, across every phase. Explore oncology case studies: https://ow.ly/2Xqk50WY1mg

From molecule to market - see how ICON supports oncology sponsors with tailored strategies, from logistics to regulatory, across every phase. Explore oncology case studies: https://ow.ly/Jjhf50WY1mh

ICON is pleased to invite you to an upcoming webinar titled “Introducing ICON strategic solutions FSP services: How this model supports sponsors in Korea,” taking place on 28 October at 2:00 PM KST. This session will pro...